Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (27) clinical trials

Do you suffer from itching related to atopic dermatitis (also known as eczema)? Learn more about a clinical research study for this condition.  

Phase N/A

Does your child have atopic dermatitis, also known as eczema? If so, they may qualify for a clinical research trial of the safety and effectiveness of an investigational product for eczema (also called atopic dermatitis).  

Phase N/A

A randomized, double-blind, placebo-controlled, phase 3 research study meant to evaluate the safety and efficacy of injectable lebrikizumab compared with injectable placebo in patients with moderate-to-severe atopic dermatitis (AD). The ADvocate 2 Study consists of three parts: a screening period, which may last up to 30 days, a treatment period, ...

Phase

A randomized, double-blind, placebo-controlled, phase 3 research study meant to evaluate the safety and efficacy of injectable lebrikizumab compared with injectable placebo in patients with moderate-to-severe atopic dermatitis (AD).  The ADvocate 1 Study consists of three parts: a screening period, which may last up to 30 days, a treatment period, which ...

Phase

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety ...

Phase N/A

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, genomic methods can expand our understanding of the human microbiome and skin diseases. Chronic dermatitis is typical among rare primary ...

Phase N/A

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult participants with moderate to severe Atopic dermatitis (AD) who are candidates for systemic therapy.

Phase

A Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis

The purpose of this study is to assess the safety and efficacy of risankizumab for the treatment of moderate to severe atopic dermatitis (AD) in adult and adolescent subjects.

Phase

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

The study will consist of a 30-day Screening period, a 7-day Run-In period, a 12-week Placebo-Controlled Treatment period followed by a 4-week Active Extension period and a Follow Up visit approximately 7 days after the last dose of study drug. All subjects will sign an informed consent form (ICF) and ...

Phase

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Study of the long term safety of serlopitant for the treatment of pruritus in adults.

Phase